Key facts
- KIVO’s last known valuation is $13.5M (Dec 2022).
- It has raised $12.8M; the latest was Later Stage VC ($5.1M) in Dec 2025.
- Notable investors include Hatteras Venture Partners, The R-Group, Boston Millennia Partners, Cascade Seed Fund, Facet Life Sciences — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for KIVO
- ·The full record, as it builds
Funding rounds
No funding rounds for KIVO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KIVO
Developer of a document management and collaboration platform designed to serve early-stage life science organizations. The company's platform offers orchestration tools that enable submission assembly and management to facilitate regulatory publishing and content tracking across submissions, enabling organizations to optimize their own regulated development.
- Sector
- Information Technology
- HQ
- Portland, OR, United States
- Founded
- 2012
- Employees
- 41
- Website
- kivo.io/
- Ownership
- Privately Held (backing)
KIVO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KIVO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KIVO in its N-PORT filings yet. We sweep new filings monthly.